Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series

Güler Özden M., Ozdemir H., Şentürk N.

DERMATOLOGIC THERAPY, vol.33, no.2, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.1111/dth.13229
  • Journal Name: DERMATOLOGIC THERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Keywords: intravenous immunoglobuline, livedoid vasculopathy, therapy-systemic, THERAPY
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

We report a retrospective analysis the efficacy of high-dose intravenous immunoglobulins on 9 patients with Livedoid vasculopathy for whom resistant to immunosuppressants plus anticoagulants or could not be prescribed. Intravenous immunoglobulins were used 2 g/kg per month in these patients. The treatment induced stabilization of the disease and all patients demonstrated improvement with IVIg. Complete and partial clinical response was achieved in 6 and 3 patients respectively.